OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Showing 1-25 of 67 citing articles:
Effects of nanoparticle size, shape, and zeta potential on drug delivery
Kıvılcım Öztürk, Meryem Kaplan, Sema Çalış
International Journal of Pharmaceutics (2024), pp. 124799-124799
Closed Access | Times Cited: 25
Kıvılcım Öztürk, Meryem Kaplan, Sema Çalış
International Journal of Pharmaceutics (2024), pp. 124799-124799
Closed Access | Times Cited: 25
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 779-811
Open Access | Times Cited: 10
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 779-811
Open Access | Times Cited: 10
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 7
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 7
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 17
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 17
Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
Yeung Wu, Sinuo Yu, Irene de Lázaro
Nanoscale (2024) Vol. 16, Iss. 14, pp. 6820-6836
Closed Access | Times Cited: 6
Yeung Wu, Sinuo Yu, Irene de Lázaro
Nanoscale (2024) Vol. 16, Iss. 14, pp. 6820-6836
Closed Access | Times Cited: 6
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines
Mingzhu Li, Lei Liu, Xiaoli Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 666-666
Open Access | Times Cited: 5
Mingzhu Li, Lei Liu, Xiaoli Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 666-666
Open Access | Times Cited: 5
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 5
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 5
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Zhaozhao Chen, Anqi Ren, Yingying Li, et al.
British Journal of Haematology (2025) Vol. 206, Iss. 2, pp. 628-643
Open Access
Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access
Revolutionizing Heart Failure Therapy: Harnessing IVT mRNA and Fusion Protein Technology to Prolong rhBNP Half-Life
You-Zhong Guo, Tao Sun, Mengyao Li, et al.
Pharmaceutical Research (2025)
Open Access
You-Zhong Guo, Tao Sun, Mengyao Li, et al.
Pharmaceutical Research (2025)
Open Access
ALC-0315 Lipid-Based mRNA LNP Induces Stronger Cellular Immune Responses Postvaccination
Zuchen Song, Lan Jin, Lina Jiao, et al.
Molecular Pharmaceutics (2025)
Closed Access
Zuchen Song, Lan Jin, Lina Jiao, et al.
Molecular Pharmaceutics (2025)
Closed Access
The Multifaceted Roles of MicroRNA-181 in Stem Cell Differentiation and Cancer Stem Cell Plasticity
Chun Yang, Rui Wang, Pierre Hardy
Cells (2025) Vol. 14, Iss. 2, pp. 132-132
Open Access
Chun Yang, Rui Wang, Pierre Hardy
Cells (2025) Vol. 14, Iss. 2, pp. 132-132
Open Access
Robust peptide/RNA complexes prepared with microfluidic mixing for pulmonary delivery by nebulisation
Cheng Ma, Michael Y.T. Chow, Chengyang Zhang, et al.
Drug Delivery and Translational Research (2025)
Open Access
Cheng Ma, Michael Y.T. Chow, Chengyang Zhang, et al.
Drug Delivery and Translational Research (2025)
Open Access
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite generates a local immunostimulatory niche for cancer immunotherapy
Yining Zhu, Zhi‐Cheng Yao, S.-H. Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Yining Zhu, Zhi‐Cheng Yao, S.-H. Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery
Yue Xu, Fanglin Gong, Alex Golubovic, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Yue Xu, Fanglin Gong, Alex Golubovic, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Current landscape of metal–organic framework-mediated nucleic acid delivery and therapeutics
Shi‐wei Feng, Yan Li, Zheng Tan, et al.
International Journal of Pharmaceutics (2025), pp. 125295-125295
Closed Access
Shi‐wei Feng, Yan Li, Zheng Tan, et al.
International Journal of Pharmaceutics (2025), pp. 125295-125295
Closed Access
A Genetically Encoded Endogenous Antibody Recruitment Strategy for Innate Immune‐Mediated Killing of Cancer Cells
Justine Aelvoet, Zifu Zhong, C. Gómez, et al.
Advanced Materials (2025)
Closed Access
Justine Aelvoet, Zifu Zhong, C. Gómez, et al.
Advanced Materials (2025)
Closed Access
Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
Christopher J. De Voss, Marcellus Korompis, Shuailin Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Christopher J. De Voss, Marcellus Korompis, Shuailin Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
